Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators
Authors:
- Claus KremoserCKClaus Kremoser
- Michael AlbersMAMichael Albers
- Thomas P. BurrisTBThomas P. Burris
- Ulrich DeuschleUDUlrich Deuschle
- Manfred KoeglMKManfred Koegl
- 1 October 2007
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 12 (19-20) , 860-869
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old DrugsNew England Journal of Medicine, 2005
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Crystal Structure of the Glucocorticoid Receptor Ligand Binding Domain Reveals a Novel Mode of Receptor Dimerization and Coactivator RecognitionCell, 2002
- Nuclear Hormone Receptors and Gene ExpressionPhysiological Reviews, 2001
- RaloxifeneDrugs, 2000
- The nuclear receptor superfamily: The second decadeCell, 1995
- Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-αNature, 1995
- Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.Journal of Clinical Investigation, 1994
- Refined solution structure of the glucocorticoid receptor DNA-binding domainBiochemistry, 1993
- The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: How receptors discriminate between their response elementsCell, 1993